News and Insights
The Numerof 2022 Global Medical Device Outlook
As our Numerof 2022 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about continuing to adapt to pressures on price and demands for value, while dealing with the aftereffects of the pandemic.
Across the globe, engagement with stakeholders will require new approaches as systems and practices continue to limit representative access in some therapeutic areas. This will force continued innovation – not just in your engagement efforts, but organizationally, in the way you structure and support your commercial approach. The need for new and different ways to engage with healthcare executives, physicians, and payers will not be going away anytime soon.
Regulators will continue tough enforcement, especially in the adverse event reporting universe. Globally, cost effectiveness evidence will play an ever more significant role in approvals. Given ongoing economic pressures, government payers worldwide will insist on transparency for comparative quality and pricing, as well as comparative effectiveness research, real world evidence and risk-based pricing.
Demanding evidence of better outcomes and lower costs, private payers will continue to expand value-based contracting, reference pricing, and direct purchasing of devices. Consumers will get more involved in choosing diagnostic tests as they also shop for lower cost, higher quality procedures. Employers seeking to reduce surgical and procedure costs while also improving employee health outcomes will create opportunities for innovative medical device makers.
In the U.S., healthcare delivery continues to centralize buying decisions in cross functional committees. Better positioning with integrated delivery networks (IDNs) will be key to future success.
Given this outlook, what’s next? We recommend these key action steps:
- Redesign commercial models to reach key decision makers
- Align R&D, Medical Affairs, and Commercial functions
- Develop high value products backed by evidence
- Innovate new products/services for use across the care continuum, including health at home
- Craft compelling economic & clinical value propositions
- Recruit, train talent to engage executive decision makers
- Elevate business acumen, diagnostic and influence skills
- Create collaboration opportunities with providers, payers and payers
At Numerof & Associates, we help medical device manufacturers achieve these key action steps for success in today’s evolving healthcare landscape. From competitive strategy and ensuring evidence to demonstrate value to commercial model innovation and implementation, we have solutions. Read more about our perspectives and solutions for the medical device industry and see our case studies.